{"count": 5, "results": [{"_id": "39689991", "pmid": 39689991, "title": "Association Between Hypoglycemia Agents and Long-term Survival Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin Immunotherapy.", "journal": "Eur Urol Oncol", "authors": ["Liu K", "Zhao H", "Chen X", "Wu H", "Wong CH", "Ko IC", "Nicoletti R", "Chiu PK", "Ng CF", "Teoh JY"], "date": "2024-12-16T00:00:00Z", "doi": "10.1016/j.euo.2024.12.002", "meta_date_publication": "2024 Dec 16", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50260.535, "text_hl": "BACKGROUND AND OBJECTIVE: There is a lack of data on the impact of @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@hypoglycemia@@@ agents, especially @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, on prognosis for non-@<m>DISEASE_Non_Muscle_Invasive_Bladder_Neoplasms</m> @DISEASE_MESH:D000093284 @@@muscle-invasive bladder cancer@@@ (@<m>DISEASE_Non_Muscle_Invasive_Bladder_Neoplasms</m> @DISEASE_MESH:D000093284 @@@NMIBC@@@). ", "citations": {"NLM": "Liu K, Zhao H, Chen X, Wu H, Wong CH, Ko IC, Nicoletti R, Chiu PK, Ng CF, Teoh JY. Association Between Hypoglycemia Agents and Long-term Survival Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin Immunotherapy. Eur Urol Oncol. 2024 Dec 16;():. PMID: 39689991", "BibTeX": "@article{39689991, title={Association Between Hypoglycemia Agents and Long-term Survival Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin Immunotherapy.}, author={Liu K and Zhao H and Chen X and Wu H and Wong CH and Ko IC and Nicoletti R and Chiu PK and Ng CF and Teoh JY}, journal={Eur Urol Oncol}}"}}, {"_id": "39952876", "pmid": 39952876, "title": "Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients With Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.", "journal": "Clin Genitourin Cancer", "authors": ["Tsuboi I", "Matsukawa A", "Kardoust Parizi M", "Schulz RJ", "Mancon S", "Fazekas T", "Miszczyk M", "Cadenar A", "Laukhtina E", "Rajwa P", "Kawada T", "Katayama S", "Iwata T", "Bekku K", "Yanagisawa T", "Miki J", "Kimura T", "Wada K", "Karakiewicz PI", "Chlosta P", "Teoh J", "Araki M", "Shariat SF"], "date": "2025-01-23T00:00:00Z", "doi": "10.1016/j.clgc.2025.102306", "meta_date_publication": "2025 Jan 23", "meta_volume": "", "meta_issue": "", "meta_pages": "102306", "score": 50249.758, "text_hl": "We identified 18 eligible studies (14 RCTs and 4 prospective trials) comprising 4,593 @<m>DISEASE_Non_Muscle_Invasive_Bladder_Neoplasms</m> @DISEASE_MESH:D000093284 @@@NMIBC@@@ @SPECIES_9606 @@@patients@@@, which investigated pharmacological interventions (eg, @CHEMICAL_Selenium @CHEMICAL_MESH:D012643 @@@selenium@@@, vitamins, @SPECIES_1582 @@@Lactobacillus casei@@@, @CHEMICAL_Celecoxib @CHEMICAL_MESH:D000068579 @@@celecoxib@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, mistletoe lectin) and lifestyle modifications (diet). ", "citations": {"NLM": "Tsuboi I, Matsukawa A, Kardoust Parizi M, Schulz RJ, Mancon S, Fazekas T, Miszczyk M, Cadenar A, Laukhtina E, Rajwa P, Kawada T, Katayama S, Iwata T, Bekku K, Yanagisawa T, Miki J, Kimura T, Wada K, Karakiewicz PI, Chlosta P, Teoh J, Araki M, Shariat SF. Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients With Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. Clin Genitourin Cancer. 2025 Jan 23;():102306. PMID: 39952876", "BibTeX": "@article{39952876, title={Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients With Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.}, author={Tsuboi I and Matsukawa A and Kardoust Parizi M and Schulz RJ and Mancon S and Fazekas T and Miszczyk M and Cadenar A and Laukhtina E and Rajwa P and Kawada T and Katayama S and Iwata T and Bekku K and Yanagisawa T and Miki J and Kimura T and Wada K and Karakiewicz PI and Chlosta P and Teoh J and Araki M and Shariat SF}, journal={Clin Genitourin Cancer}, pages={102306}}"}}, {"_id": "29485035", "pmid": 29485035, "title": "Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis.", "journal": "Can Urol Assoc J", "authors": ["Richard PO", "Ahmad AE", "Bashir S", "Zlotta A", "Bhindi B", "Leao R", "Nayan M", "Mohammed A", "Fleshner NE", "Kulkarni GS"], "date": "2018-06-01T00:00:00Z", "doi": "10.5489/cuaj.4870", "meta_date_publication": "2018 Jun", "meta_volume": "12", "meta_issue": "6", "meta_pages": "203-210", "score": 50061.95, "text_hl": "Cumulative use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and other hypoglycemic agent were calculated before and after @<m>DISEASE_Non_Muscle_Invasive_Bladder_Neoplasms</m> @DISEASE_MESH:D000093284 @@@NMIBC@@@ diagnosis. ", "citations": {"NLM": "Richard PO, Ahmad AE, Bashir S, Zlotta A, Bhindi B, Leao R, Nayan M, Mohammed A, Fleshner NE, Kulkarni GS. Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis. Can Urol Assoc J. 2018 Jun;12(6):203-210. PMID: 29485035", "BibTeX": "@article{29485035, title={Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis.}, author={Richard PO and Ahmad AE and Bashir S and Zlotta A and Bhindi B and Leao R and Nayan M and Mohammed A and Fleshner NE and Kulkarni GS}, journal={Can Urol Assoc J}, volume={12}, number={6}, pages={203-210}}"}}, {"_id": "31752752", "pmid": 31752752, "pmcid": "PMC6873510", "title": "Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer", "journal": "BMC Cancer", "authors": ["Molenaar RJ", "van Hattum JW", "Brummelhuis IS", "Oddens JR", "Savci-Heijink CD", "Boevé ER", "van der Meer SA", "Witjes JF", "Pollak MN", "de Reijke TM", "Wilmink JW"], "date": "2019-11-21T00:00:00Z", "doi": "10.1186/s12885-019-6346-1", "meta_date_publication": "2019 Nov 21", "meta_volume": "19", "meta_issue": "1", "meta_pages": "1133", "score": 50061.414, "text_hl": "Preclinical studies show the potential role of oral @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment in the management of @<m>DISEASE_Non_Muscle_Invasive_Bladder_Neoplasms</m> @DISEASE_MESH:D000093284 @@@NMIBC@@@. ", "citations": {"NLM": "Molenaar RJ, van Hattum JW, Brummelhuis IS, Oddens JR, Savci-Heijink CD, Boevé ER, van der Meer SA, Witjes JF, Pollak MN, de Reijke TM, Wilmink JW. Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer BMC Cancer. 2019 Nov 21;19(1):1133. PMID: 31752752", "BibTeX": "@article{31752752, title={Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer}, author={Molenaar RJ and van Hattum JW and Brummelhuis IS and Oddens JR and Savci-Heijink CD and Boevé ER and van der Meer SA and Witjes JF and Pollak MN and de Reijke TM and Wilmink JW}, journal={BMC Cancer}, volume={19}, number={1}, pages={1133}}"}}, {"_id": "24053906", "pmid": 24053906, "title": "Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.", "journal": "BJU Int", "authors": ["Rieken M", "Xylinas E", "Kluth L", "Crivelli JJ", "Chrystal J", "Faison T", "Lotan Y", "Karakiewicz PI", "Fajkovic H", "Babjuk M", "Kautzky-Willer A", "Bachmann A", "Scherr DS", "Shariat SF"], "date": "2013-12-01T00:00:00Z", "doi": "10.1111/bju.12448", "meta_date_publication": "2013 Dec", "meta_volume": "112", "meta_issue": "8", "meta_pages": "1105-12", "score": 50059.723, "text_hl": "CONCLUSION: @SPECIES_9606 @@@Patients@@@ with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@ and @<m>DISEASE_Non_Muscle_Invasive_Bladder_Neoplasms</m> @DISEASE_MESH:D000093284 @@@NMIBC@@@ who do not take @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ seem to be at an increased risk of disease recurrence and progression; @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use seems to exert a protective effect with regard to disease recurrence. ", "citations": {"NLM": "Rieken M, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Faison T, Lotan Y, Karakiewicz PI, Fajkovic H, Babjuk M, Kautzky-Willer A, Bachmann A, Scherr DS, Shariat SF. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer. BJU Int. 2013 Dec;112(8):1105-12. PMID: 24053906", "BibTeX": "@article{24053906, title={Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.}, author={Rieken M and Xylinas E and Kluth L and Crivelli JJ and Chrystal J and Faison T and Lotan Y and Karakiewicz PI and Fajkovic H and Babjuk M and Kautzky-Willer A and Bachmann A and Scherr DS and Shariat SF}, journal={BJU Int}, volume={112}, number={8}, pages={1105-12}}"}}]}